Travere Therapeutics Inc (TVTX)

06:41 AM

How Travere Therapeutics Inc. stock compares to industry benchmarks2025 Analyst Calls & High Return Stock Watch Alerts - newser.com

06:41 AM

06:28 AM

168,000 Shares in Travere Therapeutics, Inc. $TVTX Bought by Hussman Strategic Advisors Inc. - MarketBeat

06:28 AM

05:27 AM

Can Travere Therapeutics Inc. stock outperform in 2025 bull marketWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com

05:27 AM

02:27 AM

Real time scanner hits for Travere Therapeutics Inc. explainedPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com

02:27 AM

01:49 AM

What makes Travere Therapeutics Inc. stock attractive to growth fundsRecession Risk & Weekly High Return Forecasts - newser.com

01:49 AM

Nov 03, 2025

How geopolitical tensions affect Travere Therapeutics Inc. stockIPO Watch & Long-Term Investment Growth Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Travere Therapeutics (TVTX) Climbs 25% on Impressive Earnings - MSN

Nov 03, 2025

Nov 03, 2025

Does Travere Therapeutics Inc. show high probability of reboundJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Detecting support and resistance levels for Travere Therapeutics Inc.July 2025 Patterns & Reliable Momentum Entry Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Travere Therapeutics Inc. stock gain from strong economyJuly 2025 Momentum & Consistent Profit Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Travere Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Market Mood & Advanced Technical Analysis Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Results: Travere Therapeutics, Inc. Exceeded Expectations And The Consensus Lifted Next Year's Outlook - Yahoo Finance

Nov 03, 2025

Nov 03, 2025

What recovery options are there for Travere Therapeutics Inc.Take Profit & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Travere Therapeutics Inc. stock hit analyst price targetsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Cantor Fitzgerald Issues Negative Estimate for TVTX Earnings - MarketBeat

Nov 03, 2025

Nov 03, 2025

Will Travere Therapeutics Inc. stock outperform international peersEarnings Growth Summary & Weekly Hot Stock Watchlists - newser.com

Nov 03, 2025

Nov 03, 2025

What momentum shifts mean for Travere Therapeutics Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

How moving averages guide Travere Therapeutics Inc. tradingMarket Performance Summary & Precise Swing Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics (TVTX) Hits Fresh High on Impressive Earnings, Bullish Outlook - MSN

Nov 02, 2025

Nov 02, 2025

What indicators show strength in Travere Therapeutics Inc.July 2025 Institutional & Long-Term Investment Growth Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Pattern recognition hints at Travere Therapeutics Inc. upside2025 Market Trends & Community Consensus Stock Picks - newser.com

Nov 02, 2025

Nov 02, 2025

When is the best time to exit Travere Therapeutics Inc.CEO Change & Free High Return Stock Watch Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics Stock (TVTX) Opinions on Q3 Earnings Surge - Quiver Quantitative

Nov 02, 2025

Nov 02, 2025

Jennison Associates LLC Sells 80,602 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics Reports Strong Q3 2025 Growth - MSN

Nov 02, 2025

Nov 02, 2025

10 Stocks With Easy 20-40% Gains - Insider Monkey

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 02, 2025

Nov 01, 2025

TD Cowen Forecasts Strong Price Appreciation for Travere Therapeutics (NASDAQ:TVTX) Stock - MarketBeat

Nov 01, 2025

Nov 01, 2025

Why Travere Therapeutics Inc. stock could outperform in 2025Market Trend Report & Reliable Price Breakout Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat

Nov 01, 2025

Nov 01, 2025

A Look at Travere Therapeutics's Valuation Following Strong Q3 Profit and FILSPARI Momentum - Yahoo Finance

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics (NASDAQ:TVTX) Reaches New 1-Year High Following Earnings Beat - MarketBeat

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics (TVTX) Is Up 25.3% After FILSPARI Drives Q3 Profit Turnaround and Global Milestone - Yahoo Finance

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics stock hits 52-week high at 33.66 USD By Investing.com - Investing.com Australia

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics Inc (TVTX) Stock Price, Trades & News - GuruFocus

Nov 01, 2025

Nov 01, 2025

TD Cowen Maintains Travere Therapeutics (TVTX) Buy Recommendation - MSN

Nov 01, 2025

Oct 31, 2025

Travere Therapeutics (TVTX): Unprofitable But Forecast 67% Annual Earnings Growth Challenges Bearish Narratives - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

TD Cowen Raises Price Target for Travere Therapeutics (TVTX) to $40 | TVTX Stock News - GuruFocus

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics’ Strong Quarter and Future Prospects - TipRanks

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics Delivers Growth As FILSPARI Drives Profits - Finimize

Oct 31, 2025

Oct 31, 2025

Eric Dube Sells 92,872 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock - MarketBeat

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $79,860.00 in Stock - MarketBeat

Oct 31, 2025

Oct 31, 2025

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CEO Sells 27,128 Shares of Stock - MarketBeat

Oct 31, 2025

Oct 31, 2025

Travere signals readiness for rapid FILSPARI launch in FSGS as Q3 2025 revenue hits $164.9M - MSN

Oct 31, 2025